Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay
Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay
复制标题
流式细胞术 BCR-ABL 免疫珠测定的实验室评估
DOI:
10.1515/cclm.2011.834
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
J. Kappelmayer
中科院分区:
文献类型:
--
作者:
Z. Hevessy;R. Hudák;Valéria Kiss;P. Antal;M. Udvardy;L. Rejtő;L. Szerafin;J. Kappelmayer
Abstract Background: A new flow cytometric (FC) BCR-ABL immunobead assay has been developed recently. Here we present the laboratory evaluation of the commercially available kit. Methods: Mononuclear cells were isolated, lysed and processed according to the instructions of the manufacturer. Anti-BCR antibodies adsorbed to capture beads bind the BCR-ABL fusion proteins of the lysed cells, a phycoerythrin (PE)-conjugated anti-ABL antibody is the detector reagent and mean fluorescence intensity (MFI) signals were recorded by flow cytometry. Detection of t(9;22)(q34;q11) translocation was carried out with a quantitative PCR assay. Results: MFI results of 20 normal peripheral blood samples were 88±8 (mean±SD), CV 9%. K562 cells were used as positive control. Within-batch imprecision was excellent (3.7% in the normal and 10% in the pathological range). Cut-off was chosen at MFI 112, where both sensitivity and specificity were 100%. Altogether 17 chronic myeloid leukemia (CML) and 16 acute leukemia samples were analyzed. All PCR positive samples (n=14) were positive with the FC method and negative results were also concordant (n=15). Frozen cell lysates can be stored up to 4 weeks without significant decrease of MFI signal. Conclusions: The FC BCR-ABL assay is a fast, reproducible and reliable method that may be incorporated into standard flow cytometric protocols to help clinical decision-making.
影响因子:
158.5
作者:
Druker, BJ;Talpaz, M;Sawyers, CL
通讯作者:
Sawyers, CL